# A retrospective analysis of prenatal genetic results in fetal hydronephrosis

**Authors:** Keqin Jin, Xiayuan Xu, Yue Qian, Liping Zhang, Min Hu, Jianfeng Luo, Prathap kumar Simhadri, Prathap kumar Simhadri, Prathap kumar Simhadri

PMC · DOI: 10.1371/journal.pone.0324734 · PLOS One · 2025-05-22

## TL;DR

This study examines how prenatal genetic testing helps detect chromosomal abnormalities in fetuses with hydronephrosis, finding higher detection rates in more severe cases.

## Contribution

The study shows that CMA detects additional copy number variations in fetuses with hydronephrosis, especially in mild cases.

## Key findings

- CMA detected 15 copy number variations in 12 out of 83 fetuses with hydronephrosis.
- Mild hydronephrosis had a significantly higher detection rate of pathogenic abnormalities (37.21%) compared to moderate to severe cases (10%).

## Abstract

To discuss the application value of technologies such as chromosome microarray analysis (CMA) in fetuses with hydronephrosis and pyelectasis.

Retrospectively collected the prenatal diagnostic data of 83 fetuses with hydronephrosis from January 2020 to July 2024. The positive rate of chromosomal abnormalities detected by different ultrasound abnormalities was statistically analyzed.

Among the 83 pregnant women, 10 cases of abnormal karyotypes were detected by invasive prenatal diagnosis, with an abnormality rate of 12.05%. Numerical chromosomal abnormalities accounted for 90%, mainly trisomy 21 and 13. In the fetuses with normal karyotype/no abnormality, CMA additionally detected 15 copy number variations (CNVs) in 12 cases. Divided into isolated hydronephrosis and non-isolated hydronephrosis groups, the detection rates of fetuses carrying pathogenic CNVs were 5.56% and 12.77% respectively, and the detection rates of fetuses carrying variants of uncertain significance (VUS) were 19.44% and 8.51% respectively. Still, the differences between the two groups were not statistically significant (P > 0.05). Divided into moderate to severe hydronephrosis group and mild hydronephrosis group, the detection rate of pathogenic abnormalities by CMA was 10% and 37.21% respectively, and the difference between the two groups was statistically significant (P < 0.05).

Hydronephrosis is associated with chromosomal abnormalities, and the rate of chromosomal abnormalities increases significantly as the degree of hydronephrosis increases. The combined use of CMA technology can detect abnormalities caused by chromosomal microdeletions and/or microduplications, which is of great value for clinical prenatal consultation.

## Linked entities

- **Diseases:** hydronephrosis (MONDO:0005510)

## Full-text entities

- **Diseases:** fetal hydronephrosis (MESH:D005315), trisomy 21 and 13 (MESH:D000073839), Hydronephrosis (MESH:D006869), pyelectasis (MESH:D058536), chromosomal abnormalities (MESH:D002869)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12097554/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12097554/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12097554/full.md

---
Source: https://tomesphere.com/paper/PMC12097554